S. Bacot, N. Bernoud-hubac, B. Chantegrel, C. Deshayes, A. Doutheau et al., Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals, The Journal of Lipid Research, vol.48, issue.4, pp.816-841, 2007.
DOI : 10.1194/jlr.M600340-JLR200
URL : https://hal.archives-ouvertes.fr/hal-00139399

S. Bunting, S. Moncada, P. Reed, J. A. Salmon, and J. R. Vane, An antiserum to 5,6-dihydro prostacyclin (PGI1) which also binds prostacyclin, Prostaglandins, vol.15, issue.4, pp.565-73, 1978.
DOI : 10.1016/0090-6980(78)90053-9

D. Boukhchache and M. Lagarde, Interactions between prostaglandin precursors during their oxygenation by human platelets, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.713, issue.2, pp.386-92, 1982.
DOI : 10.1016/0005-2760(82)90257-0

C. Calzada, R. Colas, N. Guillot, M. Guichardant, M. Laville et al., Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men, Atherosclerosis, vol.208, issue.2, pp.467-72, 2010.
DOI : 10.1016/j.atherosclerosis.2009.07.049
URL : https://hal.archives-ouvertes.fr/inserm-00416728

J. H. Capdevila, J. R. Falck, and R. W. Estabrook, Cytochrome P450 and the arachidonate cascade, FASEB J, vol.6, pp.731-737, 1992.

J. H. Capdevila, J. R. Falck, and R. C. Harris, Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase, J Lipid Res, vol.41, pp.63-81, 2000.

A. Catalá, Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions, Chemistry and Physics of Lipids, vol.157, issue.1, pp.1-11, 2009.
DOI : 10.1016/j.chemphyslip.2008.09.004

P. Chen, B. Fenet, S. Michaud, N. Tomczyk, E. Véricel et al., Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation, FEBS Letters, vol.94, issue.21, pp.3478-84, 2009.
DOI : 10.1016/j.febslet.2009.10.004
URL : https://hal.archives-ouvertes.fr/inserm-00429322

P. Chen, E. Véricel, M. Lagarde, and M. Guichardant, Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation, The FASEB Journal, vol.25, issue.1, pp.382-390, 2011.
DOI : 10.1096/fj.10-161836
URL : https://hal.archives-ouvertes.fr/inserm-00517396

R. Colas, V. Pruneta-deloche, M. Guichardant, C. Luquain-costaz, C. Cugnet-anceau et al., Increased Lipid Peroxidation in LDL from Type-2 Diabetic Patients, Lipids, vol.39, issue.8, pp.723-754, 2010.
DOI : 10.1007/s11745-010-3453-9
URL : https://hal.archives-ouvertes.fr/inserm-00511438

R. Deems, M. W. Buczynski, R. Bowers-gentry, R. Harkewicz, and E. A. Dennis, Detection and Quantitation of Eicosanoids via High Performance Liquid Chromatography???Electrospray Ionization???Mass Spectrometry, Methods Enzymol, vol.432, pp.59-82, 2007.
DOI : 10.1016/S0076-6879(07)32003-X

U. Diczfalusy, ??-Oxidation of eicosanoids, Progress in Lipid Research, vol.33, issue.4, pp.403-431, 1994.
DOI : 10.1016/0163-7827(94)90025-6

R. W. Evans and H. Sprecher, Metabolism of icosa-5,11,14-trienoic acid in human platelets and the inhibition of arachidonic acid metabolism in human platelets by icosa-5, Prostaglandins, vol.811, issue.29, pp.14-514, 1985.

L. H. Foster and S. Sumar, Selenium in health and disease: A review, Critical Reviews in Food Science and Nutrition, vol.36, issue.3, pp.211-239, 1997.
DOI : 10.1080/10408399709527773

M. Fukunaga, N. Makita, L. Roberts, J. Morrow, D. Takahashi et al., Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells, Am J Physiol, vol.264, pp.1619-1643, 1993.

M. Guichardant, S. Bacot, P. Molière, and M. Lagarde, Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.75, issue.3, pp.179-82, 2006.
DOI : 10.1016/j.plefa.2006.05.006

M. Guichardant, P. Taibi-tronche, L. B. Fay, and M. Lagarde, Covalent modifications of aminophospholipids by 4-hydroxynonenal, Free Radical Biology and Medicine, vol.25, issue.9, pp.1049-56, 1998.
DOI : 10.1016/S0891-5849(98)00149-X

M. Guichardant, L. Valette-talbi, C. Cavadini, G. Crozier, and M. Berger, Malondialdehyde measurement in urine, Journal of Chromatography B: Biomedical Sciences and Applications, vol.655, issue.1, pp.112-118, 1994.
DOI : 10.1016/0378-4347(94)00030-1

M. Hecker, M. Haurand, V. Ullrich, U. Diczfalusy, and S. Hammarström, Products, kinetics, and substrate specificity of homogeneous thromboxane synthase from human platelets: Development of a novel enzyme assay, Archives of Biochemistry and Biophysics, vol.254, issue.1, pp.124-159, 1987.
DOI : 10.1016/0003-9861(87)90088-9

D. R. Janero, Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury, Free Radical Biology and Medicine, vol.9, issue.6, pp.515-555, 1990.
DOI : 10.1016/0891-5849(90)90131-2

G. Jürgens, A. Ashy, and H. Esterbauer, Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein (a) and very-low-density lipoprotein. Use of an antiserum against 4-hydroxynonenal-modified low-density lipoprotein, Biochemical Journal, vol.265, issue.2, pp.605-613, 1990.
DOI : 10.1042/bj2650605

I. Lahaie, P. Hardy, X. Hou, H. Hasséssian, P. Asselin et al., A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels, Am J Physiol, vol.274, pp.1406-1422, 1998.

A. W. Longmire, L. J. Roberts, and J. D. Morrow, Actions of the E2-isoprostane, 8-ISO-PGE2, on the platelet thromboxane/ endoperoxide receptor in humans and rats: Additional evidence for the existence of a unique isoprostane receptor, Prostaglandins, vol.48, issue.4, pp.247-56, 1994.
DOI : 10.1016/0090-6980(94)90011-6

K. S. Montine, J. F. Quinn, J. Zhang, J. P. Fessel, L. J. Roberts et al., Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases, Chemistry and Physics of Lipids, vol.128, issue.1-2, pp.117-141, 2004.
DOI : 10.1016/j.chemphyslip.2003.10.010

J. D. Morrow and L. J. Roberts, The isoprostanes: Unique bioactive products of lipid peroxidation, Progress in Lipid Research, vol.36, issue.1, pp.1-21, 1997.
DOI : 10.1016/S0163-7827(97)00001-5

J. W. Newman, T. Watanabe, and B. D. Hammock, The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS, The Journal of Lipid Research, vol.43, issue.9, pp.1563-78, 2002.
DOI : 10.1194/jlr.D200018-JLR200

N. J. Pillon, L. Soulère, R. E. Vella, M. Croze, B. R. Caré et al., Quantitative structure???activity relationship for 4-hydroxy-2-alkenal induced cytotoxicity in L6 muscle cells, Chemico-Biological Interactions, vol.188, issue.1, pp.171-80, 2010.
DOI : 10.1016/j.cbi.2010.06.015
URL : https://hal.archives-ouvertes.fr/hal-00759515

R. C. Poulsen, K. H. Gotlinger, C. N. Serhan, and M. C. Kruger, Identification of inflammatory and proresolving lipid mediators in bone marrow and their lipidomic profiles with ovariectomy and omega-3 intake, American Journal of Hematology, vol.18, issue.6, pp.437-482, 2008.
DOI : 10.1002/ajh.21170

L. Roberts, J. Fessel, and P. , The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation, Chemistry and Physics of Lipids, vol.128, issue.1-2, pp.173-86, 2004.
DOI : 10.1016/j.chemphyslip.2003.09.016

B. Samuelsson, Leukotrienes and other lipoxygenase products, Progress in Lipid Research, vol.25, pp.13-21, 1986.
DOI : 10.1016/0163-7827(86)90006-8

C. N. Serhan, Novel Lipid Mediators and Resolution Mechanisms in Acute Inflammation, The American Journal of Pathology, vol.177, issue.4, pp.1576-91, 2010.
DOI : 10.2353/ajpath.2010.100322

C. N. Serhan and B. Samuelsson, Lipoxins: A New Series of Eicosanoids (Biosynthesis, Stereochemistry, and Biological Activities), Adv Exp Med Biol, vol.229, pp.1-14, 1988.
DOI : 10.1007/978-1-4757-0937-7_1

S. Shak and I. M. Goldstein, Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes, J Biol Chem, vol.259, pp.10181-10188, 1984.

W. L. Smith, Nutritionally essential fatty acids and biologically indispensable cyclooxygenases, Trends in Biochemical Sciences, vol.33, issue.1, pp.27-37, 2008.
DOI : 10.1016/j.tibs.2007.09.013

W. L. Smith, D. L. Dewitt, and R. M. Garavito, Cyclooxygenases: Structural, Cellular, and Molecular Biology, Annual Review of Biochemistry, vol.69, issue.1, pp.145-82, 2000.
DOI : 10.1146/annurev.biochem.69.1.145

A. A. Spector, J. A. Gordon, and S. A. Moore, Hydroxyeicosatetraenoic acids (HETEs), Progress in Lipid Research, vol.27, issue.4, pp.271-323, 1988.
DOI : 10.1016/0163-7827(88)90009-4

A. A. Spector and A. W. Norris, Action of epoxyeicosatrienoic acids on cellular function, AJP: Cell Physiology, vol.292, issue.3, pp.996-1012, 2007.
DOI : 10.1152/ajpcell.00402.2006

H. Sprecher, M. Vanrollins, F. Sun, A. Wyche, and P. Needleman, Dihomo-prostaglandins and thromboxane . A prostaglandin family from adrenic acid that may be preferentially synthesized in the kidney, J Biol Chem, vol.257, pp.3912-3920, 1982.

S. Yamamoto, Mammalian lipoxygenases: Molecular and catalytic properties, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.35, issue.4, pp.219-248, 1989.
DOI : 10.1016/0952-3278(89)90005-7